Advisory: Alert incorrectly tagged to Sparx Group Co Ltd withdrawn
An alert on research-based development-stage biopharmaceutical
company SparX Biopharmaceutical announcing first patient dosed
with SPX-303 injection was incorrectly tagged to Japan-based
holding company Sparx Group Co Ltd 8739.T , an unrelated
company, and has been withdrawn.
There will be no substitute.
STORY_NUMBER: TUAB8TFR7
STORY_DATE: 11/04/2024
STORY_TIME:[07:11:33 PM GMT]
((Bangalore.newsroom@thomsonreuters.com))